Overview
Status
Active
Registry date
2018-03-23
Share capital
5,000.00 PLN
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 325 days for 2020).
- 2025filed
- 202415/07/2025
- 202323/04/2024
- 202206/07/2023
- 202129/09/2022
- 202005/09/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles26,718 / 29,903
Top 89%
Results vs industry
Revenue
This companyUSD 15.98kMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD -1.40kMedianUSD 37.33kAverageUSD 879.18k
Operating costs
This companyUSD 6.14kMedianUSD 926.31kAverageUSD 21.06m
Assets
This companyUSD 6.54kMedianUSD 609.81kAverageUSD 11.84m
Industry
Authorized Representatives
Krzysztof Kukla – Management Board Member
Sławomir Suchorowski – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Kuklaage 40 | 50 | $675.31 | 50% |
Sławomir Suchorowskiage 47 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedaseptS.A. | $8,612,031.18 | medasept.pl | ||
| PHS Hospitalsp. z o.o. + limited partnership | $1,933,301.24 | phs.med.pl | ||
| Sonomedical Pluciński, Wojciechowski, Wituskisp. j. | $1,264,523.63 | sonomedical.pl | ||
| Medaidsp. z o.o. | $1,034,514.88 | medaid.pl | ||
| Meditechsp. z o.o. | $934,565.46 | meditech.pl | ||
| PNN Pharmaceuticals sp. z o.o.sp. k. | $267,897.16 | pnn.com.pl | ||
| Medicallenssp. z o.o. | $179,960.83 | medicallens.com | ||
| Integris Medical Polskasp. z o.o. | $159,033.76 | integrismedical.pl | ||
| Aptekssp. z o.o. | $13,537.42 | apteks.com | ||
| HA Technologiessp. z o.o. | $206.67 | amalian.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-05-13 | Address change (Ul. Logistyczna 11b, 62-080, Sady → Ul. Słoneczna 4, 64-514, Lulinek) | |
| 2024-05-13 | PKD change (Removed: 10 codes; Added: 10 codes) | |
| 2023-06-05 | Address change (Ul. Zwierzyniecka 3, 60-813, Poznań → Ul. Logistyczna 11b, 62-080, Sady) | |
| 2018-03-23 | Entered in the register |
FAQ
The main business activity of GS Global focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on March 23, 2018.
The headquarters is located at: ul. Słoneczna 4, 64-514 Lulinek.
The management board consists of: Krzysztof Kukla (Member of the Management Board) and Sławomir Suchorowski (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $9,912, representing an increase of 18.2% compared to 2023.
Yes, the company recorded a net profit of $2,100 in 2024, meaning the company decreased its profit by 68.5%.
The largest operating cost category falls under external services. This category amounted to $6,764 in 2024, representing 95% of all operating expenses.
Last updated: 2026-04-28
